Return to homepagePandemic Pact

Attoquant Diagnostics GmbH

  • Funded by Austrian Research Promotion Agency (FFG)
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Funder

    Austrian Research Promotion Agency (FFG)

  • Research Location

    Austria

  • Lead Research Institution

    Attoquant Diagnostics GmbH

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    Innovation

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Attoquant Diagnostics GmbH plans to develop and introduce a new type of diagnostic test for SARS-CoV-2. The innovative test principle should enable the simple and highly sensitive detection of infectious virus particles. The vision of the project is the implementation of the new technology as a rapid test that is to be used across the board to identify carriers of SARS-CoV-2 or its mutated variants within a few minutes.